These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4226214)

  • 41. Cardioprotective effects of Astragali Radix against isoproterenol-induced myocardial injury in rats and its possible mechanism.
    Xu XL; Ji H; Gu SY; Shao Q; Huang QJ; Cheng YP
    Phytother Res; 2008 Mar; 22(3):389-94. PubMed ID: 18058992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of isoproterenol-induced cardiac hypertrophy by beta-blocking agents in the rat.
    Szabó J; Nosztray K; Csáky L; Szegi J
    Acta Physiol Acad Sci Hung; 1976; 48(1):79-86. PubMed ID: 146398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Various factors influencing the development of experimental myocardial necrosis].
    Faltová E; Albrecht I; Parízková F; Pilný F
    Cesk Fysiol; 1973; 22(1):71-5. PubMed ID: 4730912
    [No Abstract]   [Full Text] [Related]  

  • 44. Combined Effects of Vincristine and Quercetin in Reducing Isoproterenol-Induced Cardiac Necrosis in Rats.
    Panda S; Kar A
    Cardiovasc Toxicol; 2015 Oct; 15(4):291-9. PubMed ID: 25537132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Isoproterenol cardiomegaly and dehydroepiandosterone].
    Kölbel F; Sonka J; Jirásek A; Kubelka J
    Sb Lek; 1972 Jul; 74(7):233-7. PubMed ID: 4262112
    [No Abstract]   [Full Text] [Related]  

  • 46. Cardiomyocyte apoptosis contributes to the development of catacholamine cardiomyopathy.
    Beranek JT
    Clin Chim Acta; 2001 Jun; 308(1-2):183-6. PubMed ID: 11432393
    [No Abstract]   [Full Text] [Related]  

  • 47. Nutraceutical inherent of Spinacia oleracea Linn. methanolic leaf extract ameliorates isoproterenol induced myocardial necrosis in male albino Wistar rats via mitigating inflammation.
    Vutharadhi S; Jolapuram U; Kodidhela LD
    Biomed Pharmacother; 2017 Jan; 85():239-247. PubMed ID: 27914824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxic agents and cardiomyopathies.
    Morin Y; Côté G
    Cardiovasc Clin; 1972; 4(1):245-67. PubMed ID: 4568939
    [No Abstract]   [Full Text] [Related]  

  • 49. Role of Lipistat in protection against isoproterenol induced myocardial necrosis in rats: a biochemical and histopathological study.
    Seth SD; Maulik M; Katiyar CK; Maulik SK
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):101-6. PubMed ID: 9513800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Qualitative and quantitative histoenzymatic study on isoproterenol induced myocardial necroses in rats (author's transl)].
    Ciplea AG; Bock PR
    Arzneimittelforschung; 1976; 26(5):799-812. PubMed ID: 183786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitochondrial oligomycin-sensitive ATPase during isoproterenol-induced cell injury of myocardium.
    Rendón DA; López LF
    Arch Inst Cardiol Mex; 2000; 70(2):130-5. PubMed ID: 10932797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cardioprotection by oral application of the calcium antagonist fendiline. Prevention of isoproterenol-induced myocardial necroses in rats (author's transl)].
    Ciplea AG; Bock PR
    Arzneimittelforschung; 1976; 26(10):1819-26. PubMed ID: 191038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Particulate matter inhalation exacerbates cardiopulmonary injury in a rat model of isoproterenol-induced cardiomyopathy.
    Carll AP; Haykal-Coates N; Winsett DW; Rowan WH; Hazari MS; Ledbetter AD; Nyska A; Cascio WE; Watkinson WP; Costa DL; Farraj AK
    Inhal Toxicol; 2010 Apr; 22(5):355-68. PubMed ID: 20121584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of the factors influencing cardiac growth. II. Digitoxin treatment and isoproterenol-induced cardiac hypertrophy in the rat.
    Szabó J; Nosztray K; Takács IE; Szegi J
    Acta Biol Hung; 1985; 36(3-4):305-12. PubMed ID: 2436403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations in isoproterenol-induced cardiac metabolic changes by perhexiline.
    Seth SD; Choudhury S; Manchanda SC; Gupta MP; Gupta JB
    Indian J Med Res; 1985 Feb; 81():224-9. PubMed ID: 4007969
    [No Abstract]   [Full Text] [Related]  

  • 56. [Morphological principles of cardiac hypertrophy].
    Knieriem HJ
    Verh Dtsch Ges Kreislaufforsch; 1972; 38():1-21. PubMed ID: 4268341
    [No Abstract]   [Full Text] [Related]  

  • 57. Increased expression of endothelial nitric oxide synthase and caveolin-1 in the aorta of rats with isoproterenol-induced cardiac hypertrophy.
    Krenek P; Klimas J; Kroslakova M; Gazova A; Plandorova J; Kucerova D; Fecenkova A; Svec P; Kyselovic J
    Can J Physiol Pharmacol; 2006 Dec; 84(12):1245-50. PubMed ID: 17487232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An experimental investigation to correlate changes in plasma fibrinolytic activity with isoprenaline induced myocardial damage.
    Saxena KK; Gupta B; Kulshrestha VK; Prasad DN
    J Postgrad Med; 1979 Jul; 25(3):147-53. PubMed ID: 529166
    [No Abstract]   [Full Text] [Related]  

  • 59. Quantitation of isoprenaline-induced changes in the ventricular myocardium.
    Collins P; Billings CG; Barer GR; Daly JJ; Jolly A
    Cardiovasc Res; 1975 Nov; 9(6):797-806. PubMed ID: 128414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of monoamine oxidase inhibitors on isoproterenol-induced cardiomegaly in rats.
    Stanton HC; Bowman Z; Cooper CM
    Toxicol Appl Pharmacol; 1970 Jan; 16(1):256-63. PubMed ID: 4244547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.